| pubmed-article:21584033 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21584033 | pubmed:issue | Pt 5 | lld:pubmed |
| pubmed-article:21584033 | pubmed:dateCreated | 2011-5-17 | lld:pubmed |
| pubmed-article:21584033 | pubmed:abstractText | In the structure of the title compound, C(10)H(11)BrN(4), the plane of the substituted 1,2,3-triazole ring is tilted by 14.84?(10)° with respect to the mean plane of the pyridine ring. The pyridine and closest triazole N atoms adopt an anti arrangement which removes any lone pair-lone pair repulsions between the N atoms. This conformation is further stabilized by weak intermolecular C-H?N inter-actions. There are two mol-ecules in the unit cell, which form a centrosymmetric head-to-tail dimer. The dimers are stabilized through ?-? inter-actions [centroid-centroid distance = 3.733?(4)?Å and mean inter-planar distance = 3.806?(12)?Å] between the substituted 1,2,3-triazole ring and the pyridine rings in adjacent mol-ecules. Each dimer inter-acts with two neighbouring dimers above and below, forming a slipped stack of dimers through the crystal. The 3-bromo-propyl chain sits over the pyridine ring of a neighbouring mol-ecule and the triazole rings of nearby mol-ecules are adjacent. | lld:pubmed |
| pubmed-article:21584033 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21584033 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21584033 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21584033 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21584033 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21584033 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21584033 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21584033 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21584033 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21584033 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21584033 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21584033 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21584033 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21584033 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
| pubmed-article:21584033 | pubmed:issn | 1600-5368 | lld:pubmed |
| pubmed-article:21584033 | pubmed:author | pubmed-author:CrowleyJames... | lld:pubmed |
| pubmed-article:21584033 | pubmed:author | pubmed-author:HantonLyall... | lld:pubmed |
| pubmed-article:21584033 | pubmed:author | pubmed-author:BandeenPaulin... | lld:pubmed |
| pubmed-article:21584033 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21584033 | pubmed:volume | 65 | lld:pubmed |
| pubmed-article:21584033 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21584033 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21584033 | pubmed:pagination | o999-o1000 | lld:pubmed |
| pubmed-article:21584033 | pubmed:dateRevised | 2011-11-11 | lld:pubmed |
| pubmed-article:21584033 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:21584033 | pubmed:articleTitle | 1-(3-Bromo-prop-yl)-4-(2-pyrid-yl)-1H-1,2,3-triazole. | lld:pubmed |
| pubmed-article:21584033 | pubmed:affiliation | Department of Chemistry, University of Otago, PO Box 56, Dunedin, New Zealand. | lld:pubmed |
| pubmed-article:21584033 | pubmed:publicationType | Journal Article | lld:pubmed |
